H. Lee. Moffitt Cancer Center & Research Institute, Inc.

Tampa, Florida 33612

0 studies enrolling now · 18 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, Bladder Cancer, Breast Cancer, Carcinoma, Basal Cell, Carcinoma, Small Cell Lung, Colorectal Carcinoma, Glioblastoma, Leukemia, Myelomonocytic, Chronic, Metastatic Cancer, Metastatic Castration Resistant Prostate Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma — Completed
• Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) — Completed
• Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations — Completed
• A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer — Running, not enrolling
• Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC — Stopped early
• Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia — Completed
• Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy — Completed
• RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer — Stopped early
• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis — Status unconfirmed
• CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer — Completed
• Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma — Completed
• A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer — Completed
• Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax — Completed
• A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer — Completed
• DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma — Stopped early
• A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma — Completed